By Raysonho @ Open Grid Scheduler / Grid Engine [CC0] via Wikimedia Commons
CNBC reports that Fitbit recently invested more than $6 million in a company called Sano that is working on a coin-sized patch that will monitor blood sugar. The wearables-maker already is already incorporating other data of glucose-tracking devices into its Ionic smartwatch. However, this investment suggests that the firm might be studying to incorporate a monitor more directly into its devices.
James Park, the CEO of Fitbit informed CNBC: “This fits into our strategy of looking beyond the device and thinking more about (health) solutions.
“I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment.”
Fitbit is not the only one that is interested in a built-in blood sugar monitor. Reports arose early in 2017 that Apple was actually working on one itself. However, while the product of Sano makes use of tiny needles in order to take its measurements, Apple has reportedly been going after a device that has so far proved to be unattainable — a device that is non-invasive, and continuously monitoring. For Fitbit, working this type of feature into the products of the company could be a smart move as a number of its competitors have begun to move past them in the wearables field. While Fitbit dominated the market previously, it lost quite a bit of its market share to Xiaomi and Apple in 2017, both of which took turns leading the market in 2017, from quarter to quarter.
Park ended short of saying that the future devices of Fitbit will naturally have built-in blood sugar monitors. However, this investment proves that the company is at least interested in going that direction. The tracker of Sano would not be made available to consumers for at least one more year.